To use all functions of this page, please activate cookies in your browser.
My watch list
my.bionity.com
my.bionity.com
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
Last viewed
- Tm Bioscience Cystic Fibrosis test now has CE mark
- Second Phase III study of Novartis JAK inhibitor INC424 meets primary endpoint in patients with myelofibrosis - COMFORT-II data show INC424 provides marked clinical improvement in patients with myelofibrosis, measured by reduction in spleen size at 48 weeks compared to best available therapy
- Endotis Pharma reports successful completion of the neutralization study of the anticoagulant EP217609 by avidin
- Evotec receives € 3 million payment from Sanofi - Evotec achieves second milestone in diabetes alliance with Sanofi
- Category:Heterokonts
